Status of work in February
In February, AOTMiT begins work on orders from the Minister of Health:
- Braftovi (encorafenib) for the treatment of patients with colorectal cancer
- Skyrizi (risankizumab) for the treatment of patients with Crohn’s disease
- Ramizek Plus (ramipril + bisoprolol fumarate) for the treatment of hypertension
- Ladinorm (ramipril + bisoprolol fumarate) for the treatment of hypertension or hypertension with concomitant chronic coronary syndrome
The listed order is available on the AOTMiT Public Information Bulletin.